Description
ALS2CR1 Peptide | 45-245P | Gentaur UK, US & Europe Distribution
Short Description: ALS2CR1 / NIF3L1 Peptide
Species: Human
Location: ALS2CR1 peptide corresponds to 13 amino acids of ALS2CR1.
Tested Application: Bl
Application: ALS2CR1 Peptide is used for blocking the activity of ALS2CR1 antibody (catalog number 45-245). The ALS2CR1 antibody ships at 0.5 mg/mL and the ALS2CR1 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
Physical State: Lyophilized
Buffer: ALS2CR1 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.
Concentration: N/A
Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.
NCBI Official Symbol: NIF3L1
Alternate Names: CALS-7, MDS015, ALS2CR1, My018, Putative GTP cyclohydrolase 1 type 2 NIF3L1, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein,
NCBI Gene ID: 60491
User Note: N/A
NCBI Official Name: Nif3 Ngg1 Interacting Factor 3-Like 1 (S. Cerevisiae)
Background: N/A
Disclaimer: This product is for research use only.